U.S. markets open in 1 hour 39 minutes

Veritas Farms, Inc. (VFRM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.24250.0000 (0.00%)
At close: 3:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2425
Open0.2550
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2425 - 0.2425
52 Week Range0.1100 - 1.8600
Volume73
Avg. Volume22,513
Market Cap10.094M
Beta (5Y Monthly)2.37
PE Ratio (TTM)N/A
EPS (TTM)-0.2820
Earnings DateAug 25, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Veritas Farms Signs Memorandum of Understanding With Pure Research Products, LLC to Access and Incorporate its Immune Technology in the Development of Additional Veritas Farms Products; Initiates Research Partnership
    GlobeNewswire

    Veritas Farms Signs Memorandum of Understanding With Pure Research Products, LLC to Access and Incorporate its Immune Technology in the Development of Additional Veritas Farms Products; Initiates Research Partnership

    Fort Lauderdale, FL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Veritas Farms, Inc. (OTCQB: VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce that the Company has entered into a memorandum of understanding (the “MOU”) with Pure Research Products, LLC (“Pure Research”) to access and incorporate the technology used in their Del-Immune V® brand of products to develop additional Veritas Farms full spectrum hemp oil products. Del-Immune V® and the Del-Immune line of dietary supplements use the probiotic strain Lacticaseibacillus rhamnosus (L. rhamnosus) [WF1] to boost immune function in the body. Pure Research’s proprietary formulation utilizes fragmented cells, specifically the cell wall and DNA, from the probiotic bacteria to trigger an immune modulation that boosts, strengthens, and fine-tunes the immune system. Del-Immune V® is one of the leading non-prescription cell fragment nutritional supplement supported by clinical research available in the United States.The MOU, which was signed on October 8, 2020, establishes a partnership with Pure Research to maximize the benefits of Veritas Farms’ product line through the research, development and production of a Del-Immune V® enhanced line of full spectrum hemp oil products.“The opportunity for Veritas Farms to develop full spectrum hemp products with clinically-supported immune-boosting biotechnology offers a new, innovative, powerful use for consumers to utilize hemp oil in their health routines,” Dr. Dan Connors, Vice President of Research and Development, stated. “The combination of Del-Immune V® and our full spectrum hemp oil products provides us with the potential to develop a diverse line of immune support products,” he concluded.The collaboration will endeavor to research, develop, produce, and validate the efficacy of Del-Immune V® enhanced full spectrum hemp oil products. Products that are developed through the collaboration will be co-branded “Powered by Del-Immune.” The collaboration is subject to, among other matters, the negotiation and execution of a definitive collaboration agreement.Alexander Salgado, CEO and Co-Founder, said, “We are excited to begin this research and development partnership with Pure Research Products. We strive to provide consumers with the products they need to live their healthiest lives, and now more than ever immune support is on everyone’s mind.”“With decades of experience and research behind Del-Immune V® and our probiotic products for humans and animals, and our understanding of current scientific research and evidence of cannabinoid receptors in gut microbiota, we are confident that we will not only innovate new products in the space but lead the market,” said Dr. Liubov Sichel, CEO and Chief Scientific Officer of Pure Research.About Veritas Farms, Inc.Veritas Farms, Inc. (OTCQB: VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole plant, full spectrum hemp oils, and extracts containing naturally occurring cannabinoids. The Company currently owns and operates a 140-acre farm and production facility in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company markets and sells products under its Veritas Farms™ brand and manufactures private label products for a number of leading distributors and retailers. Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications, and infused edibles, lotions, salves, and oral syringes in a variety of size formats and flavors. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.For additional information and online product purchase, visit www.theveritasfarms.com.About Pure Research Products, LLCPure Research Products, LLC was co-founded in 2002 by scientist Dr. Liubov Sichel with the intent of delivering natural immune support products based on various strains of bacteria including lacticaseibacillus rhamnosus (L. rhamnosus) which, in extracted form, is found in Del-Immune V®. Dr. Sichel developed Del-Immune V®, a fast-acting, broad-spectrum immune support supplement, based on one of the most effective microbial cell lysates used to treat a range of conditions in both humans and pets. It is the leading non-prescription cell fragment supplement backed by clinical research on the U.S. market.Del-Immune V® is an immunomodulator that supports the immune system's ability to help protect against all kinds of pathogens and foreign threats and provides immediate immune support. In addition to Del-Immune V®, Pure Research Products, offers a full line of human and pet immune support supplements. Pure Research Products, which serves customers globally, is based in Boulder, Colo., and the Del-Immune V® products are manufactured in Greenfield, Ind.For more details on Del-Immune V ®and Pure Research Products’ full line of human and pet immune support supplements, visit: www.delimmune.com and follow @delimmunev on Facebook, Instagram and Twitter.Veritas Farms, Inc. - Investor ContactToll-Free: 833-691-4367E-mail: ir@theveritasfarms.comVeritas Farms, Inc. - Social MediaInstagram:  www.instagram.com/veritasfarmsofficial/ Facebook: www.facebook.com/VeritasFarmsOfficial/  LinkedIn: www.linkedin.com/company/veritasfarms/Twitter: www.twitter.com/theveritasfarms  Cautionary Language Concerning Forward-Looking StatementsThis press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.  All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.”  Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct.  These forward-looking statements involve many risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated.  Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all.  Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission.  The Company assumes no obligation to update any of the information contained or referenced in this press release.

  • GlobeNewswire

    Veritas Farms Announces Appointment of Senior Finance and Operations Executive to Board of Directors

    Fort Lauderdale, FL, Oct. 01, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Veritas Farms, Inc. (OTCQB: VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce that the Company has appointed Thomas E. Vickers to its Board of Directors

  • GlobeNewswire

    Veritas Farms Announces Commencement of $4.0 Million Private Offering

    Fort Lauderdale, FL, Sept. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Veritas Farms, Inc. (OTCQB: VFRM), a vertically-integrated agribusiness focused on the production of full spectrum hemp extracts with naturally occurring cannabinoids, today announced that it had commenced a $4.0 million private offering to be conducted pursuant to Rule 506(b) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Offering”).In the Offering, Veritas Farms is seeking to offer and sell up to 8,000,000 Units at a price of $0.50 per Unit.  Each Unit consists of (i) two shares of our common stock; and (ii) one warrant, entitling the holder to purchase one share of our common stock at an exercise price of $0.50 at any time through August 31, 2025.  In its discretion Veritas Farms may increase the size of the Offering up to $6.0 million (12,000,000 Units).Net proceeds of the Offering will be used for marketing and sales efforts to build long-term brand equity; capital expenditures for our new Aurora, Colorado manufacturing and distribution facility; development of new strains of hemp, as well as additional products; implementation of an enterprise resource system; and working capital and other general corporate purposes.This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act of 1933, as amended (the “Securities Act”) and it is neither an offer to sell nor a solicitation of an offer to buy any securities and shall not constitute an offer to sell or a solicitation of an offer to buy, or a sale of, the Units or any other securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.  The Units or any other securities proposed to offered and sold in the Offering have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.About Veritas Farms, Inc.Veritas Farms, Inc. (OTCQB: VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole-plant, full spectrum hemp oils and extracts containing naturally occurring cannabinoids.  The Company currently operates a 140-acre farm and production facility in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp.  The Company markets and sells products under its Veritas Farms™ brand and manufactures private label products for a number of leading distributors and retailers. Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in a variety of size formats and flavors.  All Veritas Farms™ brand products are third-party laboratory tested for strength and purity.  The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.Veritas Farms, Inc. - Investor ContactToll-Free: (888) 549-7888E-mail: ir@theveritasfarms.comCautionary Language Concerning Forward-Looking StatementsThis press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.  All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.”  Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct.  These forward-looking statements involve many risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated.  Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all.  Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission.  The Company assumes no obligation to update any of the information contained or referenced in this press release.